TrialPloS one2013

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.

Jasmohan S Bajaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.